Latest On Tilray, Inc (TLRY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-30 20:46 EST | News | Tilray: New Low On Debt Offering | N/A |  |
| 2023-05-27 20:59 EST | News | Tilray Brands: A Costly And Painful Move | N/A | |
| 2023-05-26 17:11 EST | News | HEXO shareholders should vote for acquisition by Tilray: ISS | N/A | |
| 2023-05-26 17:11 EST | News | Tilray Brands prices $150M convertible notes offering | N/A | |
| 2023-05-26 17:11 EST | News | Hot Stocks: WDAY, PDD rise on earnings; ULTA dips on mixed results; LOW gains; TLRY slides | N/A | |
About Tilray, Inc (TLRY):
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, clinics, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, Germany, Israel, New Zealand, Portugal, Spain, Africa, Switzerland, the United States, Malta, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.
General
- Name Tilray, Inc
- Symbol TLRY
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 1,030
- Fiscal Year EndDecember
- IPO Date2018-07-19
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.tilray.com
Valuation
- Price/Sales (Trailing 12 Mt.) 14.59
- Price/Book (Most Recent Quarter) 11.19
- Enterprise Value Revenue 20.59
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.40
- Next Year EPS Estimate -$0.25
- Next Quarter EPS Estimate -$0.17
- Profit Margin -142%
- Operating Margin -68%
- Return on Assets -9%
- Return on Equity -82%
- Revenue 191.34 million
- Earnings Per Share -$1.23
- Revenue Per Share $1.52
- Gross Profit 25.2 million
- Quarterly Earnings Growth 19.4%
Highlights
- Market Capitalization 4.72 billion
- EBITDA -86449000
- PE Ratio -5.88
- Analyst Target Price $21.15
- Book Value Per Share $2.36
Share Statistics
- Shares Outstanding 171.76 million
- Shares Float 143.82 million
- % Held by Insiders 1682%
- % Held by Institutions 16.21%
- Shares Short 22.47 million
- Shares Short Prior Month 27.7 million
- Short Ratio 0.37
- Short % of Float 14%
- Short % of Shares Outstanding 13%
Technicals
- Beta 2.86
- 52 Week High $55.01
- 52 Week Low $3.25
- 50 Day Moving Average 27.36
- 200 Day Moving Average 13.04
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Tilray, Inc (TLRY) Dividend Calendar:
Tilray, Inc (TLRY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Tilray, Inc (TLRY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Tilray, Inc (TLRY) Chart:
Tilray, Inc (TLRY) News:
Below you will find a list of latest news for Tilray, Inc (TLRY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Tilray, Inc (TLRY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest TLRY Trades:
Tilray, Inc (TLRY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-06 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-06 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-27 | 8-K (Current report) | |
| 2020-10-20 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-16 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-10-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-15 | 8-K (Current report) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 8-K (Current report) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | 8-A12B/A (Registration of securities [Section 12(b)]) | |
| 2020-09-30 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-25 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-24 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-09-24 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-23 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-22 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-03 | 4 (Statement of changes in beneficial ownership of securities) | |
Tilray, Inc (TLRY) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tilray, Inc (TLRY). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1682%
Institutional Ownership: 1621%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-05 | Brendan Kennedy | President and CEO | Sell | 127,213.00 | 7.76 | 986,969.34 | 9,865,087.00 | |
| 2020-11-05 | Brendan Kennedy | President and CEO | Sell | 272,787.00 | 7.28 | 1,986,598.61 | 9,992,300.00 | |
| 2020-11-04 | Brendan Kennedy | President and CEO | Sell | 400,000.00 | 6.04 | 2,415,200.00 | 10,265,087.00 | |
| 2020-10-16 | Brendan Kennedy | President and CEO | Sell | 400,000.00 | 5.60 | 2,238,560.00 | 10,665,087.00 | |
| 2020-10-15 | Brendan Kennedy | President and CEO | Sell | 400,000.00 | 5.61 | 2,243,160.00 | 11,065,087.00 | |
| 2020-10-14 | Brendan Kennedy | President and CEO | Sell | 400,000.00 | 5.83 | 2,331,320.00 | 11,465,087.00 | |
| 2020-10-01 | Edward Wood JR Pastorius | Chief Revenue Officer | Buy | 6,250.00 | 117,992.00 | | ||
| 2020-10-01 | Brendan Kennedy | President and CEO | Buy | 46,875.00 | 11,876,502.00 | | ||
| 2020-10-01 | Michael Auerbach | Director | Buy | 2,188.00 | 277,114.00 | | ||
| 2020-09-30 | Maryscott Greenwood | Director | Buy | 15,313.00 | 31,704.00 | | ||
| 2020-09-30 | Maryscott Greenwood | Director | Buy | 15,383.00 | 47,087.00 | | ||
| 2020-09-23 | Brendan Kennedy | President and CEO | Sell | 500,000.00 | 4.89 | 2,443,300.00 | 3,577,466.00 | |
| 2020-09-22 | Brendan Kennedy | President and CEO | Sell | 500,000.00 | 5.13 | 2,567,050.00 | 3,577,466.00 | |
| 2020-09-21 | Brendan Kennedy | President and CEO | Sell | 500,000.00 | 5.01 | 2,504,800.00 | 3,577,466.00 | |
| 2020-09-18 | Andrew Pucher | Chief Corporate Dev Officer | Buy | 7,497.00 | 24,937.00 | | ||
| 2020-09-01 | Maryscott Greenwood | Director | Sell | 5,000.00 | 6.44 | 32,195.00 | 16,391.00 | |
| 2020-09-01 | Maryscott Greenwood | Director | Buy | 2,187.00 | 21,391.00 | | ||
| 2020-09-01 | Christine St.Clare | Director | Buy | 2,187.00 | 23,058.00 | | ||
| 2020-09-01 | Rebekah Dopp | Director | Buy | 2,187.00 | 23,120.00 | | ||
| 2020-08-03 | Michael Auerbach | Director | Sell | 75,526.00 | 7.27 | 549,421.44 | 0.00 | |